A LTHOUGH studies in many clinics have j 1 demonstrated the potentiation of antihypertensive agents by chlorothiazide,1-3 its value alone in patients with moderately severe and severe hypertension has not been established. This investigation was designed to compare the effectiveness of alternate 6-month courses of chlorothiazide alone with standard antihypertensive therapy, and to compare the results of these periods with those of a 6-month combined treatment period when patients received both chlorothiazide plus standard antihypertensive therapy.
METHODS AND MATERIALS Forty-one patients were chosen from the Hypertensive Clinic of the District of Columbia General Hospital, 11 with severe hypertension and 30 with moderately severe hypertension. The pertinent data are presented in tables 1 and 2.
Experimental Plan. Each patient was followed Work done during Dr. Finnerty 's tenure of an Established Investigatorship of The American Heart Association.
Read in part before the Thirty-first Scientific Session of the American Heart Association, San Francisco, California, October 1958. 1037 through 4 study periods. A 1-month no trentimiet period, a 6-month chlorothiazide period, a 6-month standard therapy period, and a 6-month combined therapy period. The only indication for not strictly adhering to this experimental plan was the presence of fulminating disease in some of the patients with severe hypertension that necessitated the addition of further therapy. In order to avoid the influence of climate, one half the patients of each group were started on the chlorothiazide period during the summer months and the other half during the winter months.
During the "no treatment period" and during the first 2 months of each of the other treatment periods the patients visited the clinic weekly. During the remainder of the study clinic visits were biweekly. At the beginning of the study all the patients underwent the routine clinical and laboratory studies, including a complete history and physical examination, urinalysis, blood urea nitro-.gen determination, electrocardiogram, and chest roentgenogram. These laboratory procedures were repeated during each study period.
The dose of chlorothiazide (Diuril) was 1 Gin. a day (500 mg. twice a day) in all patients. The patients were allowed to eat a regular diet; supplemental potassium was not administered. During the period of standard therapy the patients with severe hypertension received mecamylamine (Inversine) and reserpine (Harmonyl). The Further analysis of these data shows that more than a 20-mm. reduction in mean arterial pressure followed both chlorothiazide alone and standard therapy in 13 patients, followed standard therapy alone in 4 patients, and followed chlorothiazide therapy alone in 2 patients. Expressed in a different way, it can be stated that standard therapy was successful in 17 patients (13 plus 4) heart-1 pt.
heart-2 pts.
Cong. It niust be admitted that the continued good therapeutic response noted when these latter agents were substituted for ganglionic-blocking agents might not have been entirely due to these drugs. Studies in this laboratory have shown that acute reduction of arterial pressure with any agent in patients in an accelerated phase of hypertension has frequently been associated with a long period of hypotension, longer than can be accounted for by the action of the drug itself. Following acute therapy the arterial pressure frequently does not return to control levels for 6 to 8 weeks. Similarly, clinical experience attests to prolonged periods of hypotension following an acute insult to the circulation such as myocardial infarction or a cerebral vascular accident. It is as though a cycle has been interrupted or the barostat of arterial pressure has been set at a lower level. Whatever the reason for the continued good response in the patients presented here, long-term ganglionic-blocking therapy was seldom indicated. Reserving ganglionie-blocking therapy for the short-term treatment of the accelerated phase of hypertension will not only free the patient from uncomfortable side effects but will also insure sensitivity to ganglionic-blocking agents that may be life-saving at a later date.
Although chlorothiazide alone has no place in the treatment of severe hypertension, one might argue from the studies presented here that it is as effective as veratrum plus reserpine or hydralazine plus reserpine in patients with moderately severe hypertension. Its ease CHLOROTHIAZIDE AND HYPERTENSION 
